FDA Warning Letter — Live Well RX

Case 716511 — FEI 3040107398

The FDA took a Warning Letter action against Live Well RX on Sep 9, 2025 (Bee Cave, TX). The action was issued by CDER and concerns drugs products.

Action details

Facility
Live Well RX
Date
Sep 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Bee Cave, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.